Interstitial lung disease can be caused by long-term exposure to hazardous materials like asbestos or coal dust, or by an auto-immune disease like rheumatoid arthritis. Lung scarring is usually irreversible once it develops. One of the signs is a dry cough. Shortness of breath can occur at rest or after exertion, and treatment varies depending on the cause. Steroids, on the other hand, are frequently used.
The most common progressive fibrosing Interstitial Lung Disease Market (PF-ILD) is idiopathic pulmonary fibrosis (IPF); PF-ILD affects many patients with other ILD subtypes. To date, biomarker research has identified several molecular markers that predict relevant ILD endpoints such as disease presence, prognosis, and treatment response.
Read More @ https://cmiinfonest.blogspot.com/2023/02/the-global-interstitial-lung-disease.html
